Clinical trials and real-world studies consistently show that gastrointestinal symptomsnausea, vomiting, diarrhea and constipationare the most common side effects of GLP-1 receptor agonists.Harvard Health+3Nature+3PMC+3 In obesity trials in particular, constipation often shows up more frequently than it does in type 2 diabetes trials.Taylor & Francis Online+1 As a nutritionist who works every day with people struggling with IBS, chronic constipation, bloating and other functional digestive issues, Im seeing more and more clients who are also using GLP-1 medications
Since Retatrutide may be able to reduce liver fat in people with obesity, it could also prevent the progression of NAFLD (2)
This is why the over promotion of MHT and GLP-1s, as if they are something every woman should take, is indirectly beneficial to companies like MIDI, because the more people want MHT and GLP-1, the more opportunities to get subscribers for supplements, compounded hormones, and compounded GLP-1s
The biology of weight regain During GLP-1 therapy, the medication mimics natural hormones to slow down your digestion and signal fullness to your brain